Antigenic mapping of emerging SARS-CoV-2 omicron variants BM.1.1.1, BQ.1.1, and XBB.1
Lancet Microbe
.
2023 May;4(5):e294-e295.
doi: 10.1016/S2666-5247(22)00384-6.
Epub 2023 Jan 16.
Authors
Anna Z Mykytyn
1
,
Miruna E Rosu
1
,
Adinda Kok
1
,
Melanie Rissmann
1
,
Geert van Amerongen
2
,
Corine Geurtsvankessel
1
,
Rory D de Vries
1
,
Bas B Oude Munnink
1
,
Derek J Smith
3
,
Marion P G Koopmans
1
,
Mart M Lamers
1
,
Ron A M Fouchier
1
,
Bart L Haagmans
4
Affiliations
1
Viroscience Department, Erasmus Medical Center, Rotterdam 3015CN, Netherlands.
2
Viroclinics Biosciences BV, Viroclinics Xplore, Schaijk, Netherlands.
3
Center for Pathogen Evolution, Department of Zoology, University of Cambridge, Cambridge, UK.
4
Viroscience Department, Erasmus Medical Center, Rotterdam 3015CN, Netherlands. Electronic address: b.haagmans@erasmusmc.nl.
PMID:
36657480
PMCID:
PMC9842387
DOI:
10.1016/S2666-5247(22)00384-6
No abstract available
Publication types
Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
MeSH terms
COVID-19*
Humans
SARS-CoV-2 / genetics
Supplementary concepts
SARS-CoV-2 variants
Grants and funding
75N93021C00014/AI/NIAID NIH HHS/United States